High blood pressure treatment irbesartan linked to cancer


The company making these drugs called Lupin Pharmaceuticals is voluntarily recalling certain batches of irbesartan and irbesartan and hydrochlorothiazide tablets. Both of these are used to treat hypertension, with irbesartan also being prescribed in the UK.

The company says it’s received no reports of illness that appear to be related to this issue but is acting out of caution.

However, they received four statements reporting some type of illness from the irbesartan tablet, in particular.

Lupin Pharmaceuticals is recalling both of these:

  • All batches of irbesartan tablets USP 75mg, 150mg and 300mg
  • All batches of irbesartan and hydrochlorothiazide tablets USP, 150mg/12.5mg and 300mg/12.5mg.


This high blood pressure medication, also used to treat diabetic nephropathy in hypertensive patients with Type 2 diabetes, was distributed nationwide in the US.

The pharmaceutical company is currently notifying wholesalers, distributors, drug chains, and supermarkets about arrangements for the return of the recalled drugs.

This is another case of a recall linked to this medicine, with one happening in the UK earlier this August.

The Medicines and Healthcare products Regulatory Agency (MHRA) had issued a recall for 25 batches of irbesartan containing drugs.

Lupin is following the same advice and tells patients on the drugs to continue taking their medication and contact either a pharmacist, physician or a medical provider “regarding an alternative treatment”.

There are several other types of medicine for treating high blood pressure available in the UK.

Many people take a combination of different tablets, according to the NHS.

“It’s really important to take your medicine as directed. If you miss doses, it will not work as well,” stated the NHS.

Source link

Denial of responsibility! NewsConcerns is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@newsconcerns.com. The content will be deleted within 24 hours.

Leave a comment